Acertis Pharmaceuticals Licenses U.S. Commercial Rights to Licart® from IBSA

Acertis Pharmaceuticals announced that it has entered into an exclusive agreement to license the U.S. commercial rights for Licart.
Business Wire

IBSA Introduces Two New Dietary Supplements Into the U.S. Market

PARSIPPANY, N.J.--(BUSINESS WIRE)--IBSA USA announced that its Syrel™ (selenium + BioPerine ®) and Thirodium™ (iodine) brands are now available in the U.S. Manufactured and marketed by IBSA, Syrel and ...
Yahoo Finance

IBSA USA Expands Its IBSA Care Line of Dietary Supplements With Irosolv™

IBSA USA has expanded its IBSA Care line of dietary supplements with Irosolv™ (Iron 30 mg & Folic Acid 400 mcg oral film strip). (Photo: Business Wire) Product specially formulated with novel orally ...
Business Wire

Two Young Researchers from US Institutions among the Six Winners of the 12th Edition of the Fellowships Promoted by IBSA Foundation for Scientific Research

PARSIPPANY, N.J.--(BUSINESS WIRE)--Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships program, which for over a decade, has supported talented ...